ATE419847T1 - Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms - Google Patents

Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms

Info

Publication number
ATE419847T1
ATE419847T1 AT05807584T AT05807584T ATE419847T1 AT E419847 T1 ATE419847 T1 AT E419847T1 AT 05807584 T AT05807584 T AT 05807584T AT 05807584 T AT05807584 T AT 05807584T AT E419847 T1 ATE419847 T1 AT E419847T1
Authority
AT
Austria
Prior art keywords
acetyl
carinitine
treat
fibromyalgic syndrome
fibromyalgic
Prior art date
Application number
AT05807584T
Other languages
German (de)
English (en)
Inventor
Aleardo Koverech
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE419847T1 publication Critical patent/ATE419847T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT05807584T 2004-12-13 2005-11-10 Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms ATE419847T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000606A ITRM20040606A1 (it) 2004-12-13 2004-12-13 Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica.

Publications (1)

Publication Number Publication Date
ATE419847T1 true ATE419847T1 (de) 2009-01-15

Family

ID=35708966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05807584T ATE419847T1 (de) 2004-12-13 2005-11-10 Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms

Country Status (16)

Country Link
US (1) US8013016B2 (enExample)
EP (1) EP1824472B1 (enExample)
JP (1) JP5057990B2 (enExample)
KR (1) KR101240182B1 (enExample)
AT (1) ATE419847T1 (enExample)
CA (1) CA2585560C (enExample)
CY (1) CY1110576T1 (enExample)
DE (1) DE602005012317D1 (enExample)
DK (1) DK1824472T3 (enExample)
ES (1) ES2320788T3 (enExample)
IT (1) ITRM20040606A1 (enExample)
MX (1) MX2007006954A (enExample)
PL (1) PL1824472T3 (enExample)
PT (1) PT1824472E (enExample)
SI (1) SI1824472T1 (enExample)
WO (1) WO2006063639A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2840363A1 (en) * 2011-06-24 2012-12-27 K-Pax Pharmaceuticals, Inc. Compositions comprising a central nervous system stimulant and select micronutrients useful in the treatment of chronic fatigue
ES2962933T3 (es) 2020-12-14 2024-03-21 Ims Gear Se & Co Kgaa Procedimiento para la corrección de una señal de medición dependiente del tiempo de una unidad de motor-engranaje, así como procedimiento para detectar desgaste y/o un deterioro de la misma mediante este procedimiento de corrección

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
EP0681839A3 (en) * 1994-05-12 1997-11-12 Hirohiko Kuratsune A pharmaceutical preparation comprising an acylcarnitine
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US5935949A (en) * 1998-03-20 1999-08-10 Trustees Of Dartmouth College Use of androgen therapy in fibromyalgia and chronic fatigue syndrome
US6803387B1 (en) 1999-03-19 2004-10-12 Abbott Gmbh & Co. Kg Treatment of neuropathic pain or fibromyalgia
ITRM20010293A1 (it) 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
KR101027570B1 (ko) * 2002-05-03 2011-04-06 이스라엘 인스티튜트 포 바이올로지컬 리서치 중추 및 말초 신경계 장애의 치료를 위한 방법 및 조성물, 및 그에 유용한 신규 화합물

Also Published As

Publication number Publication date
EP1824472B1 (en) 2009-01-07
ITRM20040606A1 (it) 2005-03-13
JP5057990B2 (ja) 2012-10-24
US20090076146A1 (en) 2009-03-19
KR101240182B1 (ko) 2013-03-07
KR20070091317A (ko) 2007-09-10
CY1110576T1 (el) 2015-04-29
CA2585560C (en) 2013-01-08
PL1824472T3 (pl) 2009-05-29
SI1824472T1 (sl) 2009-04-30
ES2320788T3 (es) 2009-05-28
MX2007006954A (es) 2007-08-02
EP1824472A1 (en) 2007-08-29
CA2585560A1 (en) 2006-06-22
WO2006063639A1 (en) 2006-06-22
DK1824472T3 (da) 2009-03-30
JP2008534433A (ja) 2008-08-28
PT1824472E (pt) 2009-03-31
DE602005012317D1 (de) 2009-02-26
US8013016B2 (en) 2011-09-06

Similar Documents

Publication Publication Date Title
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
DE60320007D1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE457729T1 (de) Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie
UA81573C2 (en) Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients
ATE311866T1 (de) Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln zur behandlung von erkrankungen rheumatischer natur
ATE380554T1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
ATE419847T1 (de) Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE422883T1 (de) Verwendung von carnitinen zur prävention und/oder behandlung von krankheiten die durch die andropause verursacht werden
ATE476974T1 (de) Verwendung einer kombination von l-carnitin, acetyl l-carnitin und propionyl l-carnitin zur behandlung von oligoasthenoteratospermia
ATE281172T1 (de) Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms
ATE386513T1 (de) Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie
ATE445394T1 (de) Verwendung von citrullin zur herstellung eines arzneimittels zur behandlung von ans altern oder an eine bestrahlung gebundener intestinaler insuffizienz
CY1107037T1 (el) Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
DE602006021594D1 (de) Verbindung zur prävention und behandlung von links
ATE345124T1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
ATE418977T1 (de) Verwendung von phenylacetylderivaten zur herstellung eines arzneimittels zur behandlung der von-hippel-lindau-erkrankung
ATE353638T1 (de) Verwendung von nf-kappa b hemmern zur behandlung von brustdrüsenentzündung
ATE403424T1 (de) Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa
ATE442848T1 (de) Isoxazolsäure-derivat zur linderung neuropathischer schmerzen
CY1114286T1 (el) Θεραπεια συνδυασμου με glatiramer acetate και ρασαγιλινη (rasagiline) για την θεραπεια της πολλαπλης σκληρωσης

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1824472

Country of ref document: EP